YD Bio (NASDAQ:YDES) Shares Gap Up – Time to Buy?

YD Bio Limited (NASDAQ:YDES)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $7.67, but opened at $7.96. YD Bio shares last traded at $7.6360, with a volume of 866 shares changing hands.

Analyst Ratings Changes

Several equities research analysts have weighed in on YDES shares. Weiss Ratings reissued a “sell (d+)” rating on shares of YD Bio in a research note on Monday, December 29th. Wall Street Zen raised YD Bio from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, YD Bio has a consensus rating of “Sell”.

YD Bio Stock Performance

The business has a 50 day moving average price of $10.45.

Institutional Investors Weigh In On YD Bio

A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC boosted its holdings in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 58,363 shares of the biotechnology company’s stock after acquiring an additional 5,292 shares during the quarter. Geode Capital Management LLC owned 0.08% of YD Bio worth $711,000 as of its most recent SEC filing.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.